Reply to: “FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies,” “Conversion Chemotherapy for Locally Advanced Pancreatic Carcinoma: FOLFIRINOX or Gemcitabine?,” and “Chemotherapy for Locally Advanced Pancreatic Cancer: The Dilemma of David Versus Goliath After NEOPAN”
M
Michel Ducreux
(Michel Ducreux, MD, PhD, Université Paris-Saclay 11Gustave Roussy Cancer Center, Tumor Cells Dynamics, INSERM, Villejuif, France; Matthieu Texier, MD, PhD, Biostatistics, Gustave Roussy Institut de Cancérologie, Villejuif, France; and Olivier Bouche, MD, PhD, Digestive Oncology Department, CHU Reims, Reims, France)
M
Matthieu Texier
O
Olivier Bouche
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 2
Published
January 10, 2026
Pages
132-133
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (3)
M
Michel Ducreux
Michel Ducreux, MD, PhD, Université Paris-Saclay 11Gustave Roussy Cancer Center, Tumor Cells Dynamics, INSERM, Villejuif, France; Matthieu Texier, MD, PhD, Biostatistics, Gustave Roussy Institut de Cancérologie, Villejuif, France; and Olivier Bouche, MD, PhD, Digestive Oncology Department, CHU Reims, Reims, France
M
Matthieu Texier
O
Olivier Bouche
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001